Phase II study of neoadjuvant chemotherapy and radiation therapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation therapy oncology group trial 9514

Journal of Clinical Oncology

Volumn 24, Issue 4, 2006, Pages 619-625

  Kraybill, William G ^a   Harris, Jonathon ^a   Spiro, Ira J ^a   Ettinger, David S ^a   DeLaney, Thomas F ^a   Blum, Ronald H ^a   Lucas, David R ^a   Harmon, David C ^a   Letson, G Douglas ^a   Eisenberg, Burton ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DACARBAZINE; DOXORUBICIN; IFOSFAMIDE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; ANTINEOPLASTIC AGENT; MAID PROTOCOL;

ACUTE GRANULOCYTIC LEUKEMIA; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; BLOOD TOXICITY; CANCER RADIOTHERAPY; CANCER RISK; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE FREE SURVIVAL; FEMALE; FEMUR NECK FRACTURE; FEVER; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPOCALCEMIA; INFECTION; LEUKOPENIA; LIMB AMPUTATION; LIMB TUMOR; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MUCOSAL DISEASE; MULTIPLE CYCLE TREATMENT; MYELODYSPLASIA; NAUSEA; NEUROLOGIC DISEASE; OVERALL SURVIVAL; PAIN; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY TRACT DISEASE; SEPSIS; SKIN TOXICITY; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR BIOPSY; UROGENITAL TRACT DISEASE; VASCULAR DISEASE; VOMITING; AMPUTATION; LIMB; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; RISK ASSESSMENT; SARCOMA; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ADULT; AGED; AMPUTATION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; EXTREMITIES; FEMALE; HUMANS; IFOSFAMIDE; MALE; MESNA; MIDDLE AGED; NEOADJUVANT THERAPY; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; SARCOMA; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33644843999     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.02.5577     Document Type: Article

References (29)

1. Lawrence W Jr, Donegan WL, Natarajan N, et al: Adult soft tissue sarcomas: A pattern of care survey of the American College of Surgeons. Ann Surg 205:349-359, 1987
2. Lindberg RD, Martin RG, Romsdahl MM, et al: Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer 47:2391-2397, 1981
3. Rosenberg SA, Tepper J, Glatstein E, et al: The treatment of soft-tissue sarcomas of the extremities: Prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy. Ann Surg 196:305-315, 1982
4. Pisters PW, Harrison LB, Leung DH, et al: Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859-868, 1996
5. Rydholm A, Gustafson P, Rooser B, et al: Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma. J Clin Oncol 9:1757-1765, 1991
6. Baldini EH, Goldberg J, Jenner C, et al: Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk. J Clin Oncol 17:3252-3259, 1999
7. Stinson SF, DeLaney TF, Greenberg J, et al: Acute and long term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcomas. Int J Radiat Oncol Biol Phys 21:1493-1499, 1991
8. Spiro IJ, Gebhardt MC, Jennings LC, et al: Prognostic factors for local control of sarcomas of the soft tissues managed by radiation and surgery. Semin Oncol 24:540-5466, 1997
9. Potter DA, Glenn J, Kinsella T, et al: Patterns of recurrence in patients with high-grade soft tissue sarcomas. J Clin Oncol 3:353-366, 1985
10. Tierney JF, Mosseri V, Stewart LA, et al: Adjuvant chemotherapy for soft-tissue sarcoma: Review and meta-analysis of the published results of randomized clinical trials. Br J Cancer 72:469-475, 1995
11. Bramwell VHC: Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? J Clin Oncol 19:1235-1237, 2001
12. Frustaci S, Gherlinzoni F, De Paoli A, et al: Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol 19:1238-1247, 2001
13. Frustaci S, De Paoli A, Bidoli E, et al: Ifosfamide in the adjuvant therapy of soft tissue sarcomas. Oncology 65:80-84, 2003 (suppl 2)
14. Brodowicz T, Schwameis E, Widder J, et al: Intensified IFADIC chemotherapy for adult soft tissue sarcoma: A prospective randomized feasibility trial. Sarcoma 4:151-160, 2000
15. Petrioli R, Coratti A, Correale P, et al: Adjuvant epirubicin with or without ifosfamide for adult soft-tissue sarcoma. Am J Clin Oncol 25:468-473, 2002
16. Cormier JN, Huang X, Zing Y, et al: Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol 22:4567-4574, 2004
17. Gobmyer SR, Make RG, Demetri GD, et al: Neo-adjuvant chemotherapy for primary high-grade extremity soft tissue sarcoma. Ann Oncol 15:1667-1672, 2004
18. Spiro IJ, Suit H, Gebhardt M, et al: Neoadjuvant chemotherapy and radiotherapy for large soft tissue sarcomas. Proc Am Soc Clin Oncol 15:524, 1996 (abstr 168)
19. DeLaney TF, Spiro IJ, Suit HD, et al: Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 56:1117-1127, 2003
20. Weiss SW: Histologic Typing of Soft Tissue Tumors. Berlin, Springer-Verlag, 1994, pp 19-25
21. Schmidt RA, Conrad EU, Collins C, et al: Measurement of and prediction of the short-term response of soft tissue sarcomas to chemotherapy. Cancer 72:2593-2601, 1993
22. Cox JD, Stetz J, Pajak TF: Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial]. Int J Radiat Oncol Biol Phys 32:567-576, 1995
23. Kalbfleisch JD, Prentice RL: The statistical analysis of failure time data. New York, NY, Wiley, 1980, pp 163-178
24. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
25. 2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma. J Clin Oncol 23:105-112, 2005
26. Krishnan A, Smita B, Slovak ML, et al: Predictors of therapy-related leukemia and myelodysplasias following autologous transplantation for lymphoma: An assessment of risk factors. Blood 95:1488-1593, 2000
27. Chaplain G, Milan C, Sgro C, et al: Increased risk of acute leukemia after adjuvant chemotherapy for breast cancer: A population-based study. J Clin Oncol 18:2836-2842, 2000
28. Myhre JO, Kaae S, Madsen EH, et al: Histopathological grading in soft-tissue tumours: Relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scand 91:145-150, 1983
29. Stojadinovic A, Leung DHY, Allen P, et al: Primary adult soft tissue sarcoma: Time-dependent influence of prognostic variables. J Clin Oncol 20:4344-4352, 2002